Increased porphyrins in primary liver cancer mainly reflect a parallel liver disease

Gastroenterology Research and Practice

Volumn , Issue , 2009, Pages

  Kaczynski, Jerzy ^a   Hansson, G̈oran ^a   Wallerstedt, Sven ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PORPHYRIN;

ADULT; ARTICLE; BENIGN TUMOR; BILE DUCT CARCINOMA; CANCER PATIENT; FAMILY HISTORY; FECES ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIMARY TUMOR; URINALYSIS;

EID: 72449149666     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2009/402394     Document Type: Article

References (51)

1. Parkin D. M., Bray F., Ferlay J., Pisani P., Estimating the world cancer burden: Globocan 2000 International Journal of Cancer 2001 94 2 153 156 (Pubitemid 32911406)
2. Bassendine M. F., Aetiological factors in hepatocellular cancer Baillieres Clinical Gastroenterology 1987 1 1 1 16
3. The Cancer Registry, Cancer incidence in Sweden 1958-1979 1982 Stockholm, Sweden National Board of Health and Welfare
4. London W. T., Klein G., Hepatitis B virus and primary hepatocellular carcinoma Advances in Viral Oncology 1983 3 New York, NY, USA Raven 325 341
5. Gerber M. A., Relation of hepatitis C virus to hepatocellular carcinoma Journal of Hepatology 1993 17 supplement 3 108 111
6. Bassendine M. F., Alcohola major risk factor for hepatocellular carcinoma? Journal of Hepatology 1986 2 3 513 519
7. Kaczynski J., Hansson G., Wallerstedt S., Diabetes: one of few remarkable differences in clinicopathologic features between cirrhotic and noncirrhotic Swedes with hepatocellular carcinoma Digestive Diseases and Sciences 2006 51 4 796 802
8. El-Serag H. B., Hampel H., Javadi F., The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence Clinical Gastroenterology and Hepatology 2006 4 3 369 380
9. Lithner F., Wetterberg L., Hepatocellular carcinoma in patients with acute intermittent porphyria Acta Medica Scandinavica 1984 215 3 271 274
10. Hardell L., Bengtsson N. O., Jonsson U., Eriksson S, Larsson L. G., Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyriaan epidemiological investigation British Journal of Cancer 1984 50 3 389 397
11. Bengtsson N. O., Hardell L., Porphyrias, porphyrins and hepatocellular cancer British Journal of Cancer 1986 54 1 115 117
12. Kauppinen R., Mustajoki P., Acute hepatic porphyria and hepatocellular carcinoma British Journal of Cancer 1988 57 1 117 120
13. Andersson C., Bjersing L., Lithner F., The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria Journal of Internal Medicine 1996 240 4 195 201 (Pubitemid 26356041)
14. Andant C., Puy H., Faivre J., Deybach J. C., Acute hepatic porphyrias and primary liver cancer The New England Journal of Medicine 1998 338 25 1853 1854
15. Linet M. S., Gridley G., Nyren O., Primary liver cancer, other malignancies, and mortality risks following porphyria: a cohort study in Denmark and Sweden American Journal of Epidemiology 1999 149 11 1010 1015
16. Andant C., Puy H., Bogard C., Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors Journal of Hepatology 2000 32 6 933 939
17. Kordac V., Frequency of occurrence of hepatocellular carcinoma in patients with porphyria cutanea tarda in long-term follow-up Neoplasma 1972 19 2 135 139
18. Solis J. A., Betancor P., Campos R., Association of porphyria cutanea tarda and primary liver cancer Journal of Dermatology 1982 9 2 131 137
19. Packe G. E., Clarke C. W. F., Is porphyria cutanea tarda a risk factor in the development of hepatocellular carcinoma? Oncology 1985 42 1 44 47
20. Salata H., Cortes J. M., Enriquez de Salamanca R., Porphyria cutanea tarda and hepatocellular carcinomafrequency of occurrence and related factors Journal of Hepatology 1985 1 5 477 487
21. Siersema P. D., ten Kate F. J. W., Mulder P. G. H., Wilson J. H. P., Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence Liver 1992 12 2 56 61
22. Fracanzani A. L., Taioli E., Sampietro M., Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease Journal of Hepatology 2001 35 4 498 503 (Pubitemid 32964449)
23. Germanaud J., Luthier F., Causse X., A case of association between hepatocellular carcinoma and porphyria variegata Scandinavian Journal of Gastroenterology 1994 29 7 671 672
24. Andant C., Puy H., Deybach J. C., Soule J. C., Nordmann Y., Occurrence of hepatocellular carcinoma in a case of hereditary coproporphyria American Journal of Gastroenterology 1997 92 8 1389 1390
25. Kaczynski J., Hansson G., Thunell S., Wetterberg L., Wallerstedt S., Erythrocyte porphobilinogen deaminase activity and primary liver cancer Journal of Internal Medicine 1995 237 3 309 313
26. Gubler J. G., Bargetzi M. J., Meyer U. A., Primary liver carcinoma in two sisters with acute intermittent porphyria American Journal of Medicine 1990 89 4 540 541
27. Bjersing L., Andersson C., Lithner F., Hepatocellular carcinoma in patients from northern Sweden with acute intermittent porphyria: morphology and mutations Cancer Epidemiology Biomarkers and Prevention 1996 5 5 393 397
28. Herrero C., Vicente A., Bruguera M., Is hepatitis C virus infection a trigger of porphyria cutanea tarda? The Lancet 1993 341 8848 788 789
29. Gisbert J. P., Garcia-Buey L., Alonso A., Hepatocellular carcinoma risk in patients with porphyria cutanea tarda European Journal of Gastroenterology and Hepatology 2004 16 7 689 692
30. Rossmann-Ringdahl I., Olsson R., Porphyria cutanea tarda in a Swedish population: risk factors and complications Acta Dermato-Venereologica 2005 85 4 337 341
31. Lim H. W., Mascaro J. M., The porphyrias and hepatocellular carcinoma Dermatologic Clinics 1995 13 1 135 142
32. DeCastro M., Sanchez J., Herrera J. H., Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda Hepatology 1993 17 4 551 557
33. Kassianides C., Kew M. C., The clinical manifestations and natural history of hepatocellular carcinoma Gastroenterology Clinics of North America 1987 16 4 553 562
34. Johnson P. J., The clinical features and natural history of malignant liver tumours Baillieres Clinical Gastroenterology 1987 1 1 17 34
35. Ochiai T., Morishima T., Kondo M., Symptomatic porphyria secondary to hepatocellular carcinoma British Journal of Dermatology 1997 136 1 129 131
36. Huang W. S., Liao L. Y., Wang C. S., Chen P. H., Hepatocellular carcinoma presenting with acquired porphyria: a case report and review of the literature Changgeng Yi Xue Za Zhi 1999 22 1 111 116
37. Lindstedt G., Nillroth L. W., von Schele C., Schelin U., Swolin B., Zettergren L., Sen debut av porfyri hos en patient med primr levercancer Lkartidningen 1973 70 47 4265 4266
38. Doss M., Martini G. A., Remmer H., Bolt H. M., Bannasch P., Popper H., Porphyrin metabolism and liver tumors Primary Liver Tumors 1978 Baltimore, Md, USA University Park Press 409 420
39. Ostrowski J., Kosecki P., Martynska M., Milewski B., Urinary porphyrins in liver disease Scandinavian Journal of Gastroenterology 1984 19 6 862 866
40. Anthony P. P., MacSween R. N. M., Anthony P. P., Scheuer P. J., Burt A. D., Portmann B. C., Tumours and tumour-like lesions of the liver and biliary tract Pathology of the Liver 1994 3rd Edinburgh, UK Churchill Livingstone 635 711
41. International working party, Terminology of nodular hepatocellular lesions Hepatology 1995 22 983 993
42. Regan L. S., Screening for hepatocellular carcinoma in high-risk individuals Archives of Internal Medicine 1989 149 8 1741 1744
43. Kaczynski J., Hansson G., Wallerstedt S., Incidence of primary liver cancer and etiological aspectsa study of a defined population from a low endemic area British Journal of Cancer 1996 73 126 132
44. Pierach C. A., Bossenmaier I. C., Cardinal R. A., Weimer M. K., Pseudoporphyria in a patient with hepatocellular carcinoma American Journal of Medicine 1984 76 3 545 548
45. Thunell S., Diagnosis of disturbances of porphyrin metabolism Lkartidningen 1986 83 39 3242 3251
46. Wolfsen H. C., Ng C. S., Czaja A. J., Hepatitis C virus and porphyria cutanea tarda. A newly recognized association Gastroenterology 1993 104 supplement A-23
47. Okuda K., Obata H., Nakajima Y., Prognosis of primary hepatocellular carcinoma Hepatology 1984 4 3S 6S
48. Shiu W., Dewar G., Leung N., Hepatocellular carcinoma in Hong Kong: clinical study on 340 cases Oncology 1990 47 3 241 245
49. Kaczynski J., Hansson G., Wallerstedt S., Clinical features in hepatocellular carcinoma and the impact of autopsy on diagnosis. A study of 530 cases from a low-endemicity area Hepato-Gastroenterology 2005 52 66 1798 1802
50. Thunell S., Porphyrins, porphyrin metabolism and porphyrias. I. Update Scandinavian Journal of Clinical and Laboratory Investigation 2000 60 7 509 540
51. Thunell S., Harper P., Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tardasuggestions for a handling programme Scandinavian Journal of Clinical and Laboratory Investigation 2000 60 7 561 579 (Pubitemid 32052517)